{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:34:13Z","timestamp":1787758453162,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Identifying tumor markers that can be used to determine the biological behavior of tumors and predicting their prognosis may be helpful in choosing treatment strategies. Besides the differences in the embryological and histological anatomy of the larynx in this regard, the possibility of molecular causes that can explain the different clinical behaviors has always been a question for the scientific world.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>In this study, we aimed to investigate whether there were any immunohistochemically molecular differences among laryngeal carcinoma cases originating from two different anatomical regions of the larynx.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods:<\/jats:title>\n                    <jats:p>The study group consisted of 43 patients. The rate of supraglottic cancers was 41.8%, while the rest had glotto-subglottic tumors. Ki67, \u03b2-catenin, E-cadherin, and p53 were examined in pathology preparations obtained by laryngectomy surgeries. The data obtained were analyzed by comparing factors that may affect the prognosis of the disease and between tumors originating from the two different anatomical regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We did not see any statistically significant difference between groups for stage and grade of tumor, tumor recurrence rate, or lymphovascular or perineural invasion rated in terms of the investigated markers. In addition, there was no statistically significant difference between the two distinct groups in survival analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>With these results, our study differs from some studies in the literature, and we think that this difference could be because the cases in our study consisted of advanced stage tumors and the groups investigated had similar survival rates.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/njcp.njcp_1693_21","type":"journal-article","created":{"date-parts":[[2022,9,22]],"date-time":"2022-09-22T13:57:08Z","timestamp":1663855028000},"page":"1424-1429","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Ki-67, p-53, E-Cadherin, and \u03b2-Catenin Expression of Advanced Glotto-Subglottic and Supraglottic Larynx Carcinomas"],"prefix":"10.4103","volume":"25","author":[{"given":"A","family":"Kara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Turan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Guven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Elden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20240907","doi-asserted-by":"crossref","first-page":"7351","DOI":"10.7314\/APJCP.2014.15.17.7351","article-title":"Elevated neutrophil-to-lymphocyte ratio in squamous cell carcinoma of larynx compared to benign and precancerous laryngeal lesions","volume":"15","author":"Kum","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"key":"R2-7-20240907","first-page":"313","article-title":"Laryngeal cancer: Epidemiological data from Northern Greece and review of the literature","volume":"17","author":"Markou","year":"2013","journal-title":"Hippokratia"},{"key":"R3-7-20240907","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00405-011-1892-4","article-title":"The cadherin-catenin complex in laryngeal squamous cell carcinoma","volume":"269","author":"Galera-Ruiz","year":"2012","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R4-7-20240907","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1007\/s00405-014-3117-0","article-title":"The clinical relevance of Ki-67 expression in laryngeal squamous cell carcinoma","volume":"272","author":"Gioacchini","year":"2015","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R5-7-20240907","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.21873\/anticanres.11580","article-title":"Expression of cell cycle-related proteins p16, p27 and Ki-67 proliferating marker in laryngeal squamous cell carcinomas and in laryngeal papillomas","volume":"37","author":"Ciesielska","year":"2017","journal-title":"Anticancer Res"},{"key":"R6-7-20240907","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1007\/s00405-010-1249-4","article-title":"Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma","volume":"267","author":"Goulioumis","year":"2010","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R7-7-20240907","doi-asserted-by":"crossref","first-page":"5301","DOI":"10.7314\/APJCP.2013.14.9.5301","article-title":"Relationships between clinical behavior of laryngeal squamous cell carcinomas and expression of VEGF, MMP-9 and E-cadherin","volume":"14","author":"Akdeniz","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"R8-7-20240907","first-page":"1459","article-title":"Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinoma","volume":"29","author":"Cordes","year":"2009","journal-title":"Anticancer Res"},{"key":"R9-7-20240907","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00405-003-0699-3","article-title":"Prognostic significance of Ki-67 expression for patients with laryngeal squamous cell carcinoma primarily treated by total laryngectomy","volume":"261","author":"Acikalin","year":"2004","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R10-7-20240907","first-page":"335","article-title":"Prognostic significance of metallothionein, p53 protein and Ki-67 antigen expression in laryngeal cancer","volume":"27","author":"Pastuszewski","year":"2007","journal-title":"Anticancer Res"},{"key":"R11-7-20240907","doi-asserted-by":"crossref","first-page":"661","DOI":"10.4103\/0377-4929.72019","article-title":"Expression of Ki67 and P53 in primary squamous cell carcinoma of the larynx","volume":"53","author":"Ashraf","year":"2010","journal-title":"Indian J Pathol Microbiol"},{"key":"R12-7-20240907","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1002\/lary.28532","article-title":"Distinct Biomarker Profiles and Clinical Characteristics in T1-T2 Glottic and Supraglottic Carcinomas","volume":"130","author":"Wachters","year":"2020","journal-title":"Laryngoscope"},{"key":"R13-7-20240907","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00405-003-0651-6","article-title":"p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma","volume":"260","author":"Mielcarek-Kuchta","year":"2003","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"R14-7-20240907","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s001060050231","article-title":"Retrospektive Analyse ausgew\u00e4hlter Tumormarker (p53, PCNA, Ki67; DNA-Ploidie) und der Ultrastruktur bei Kranken mit Larynxkarzinomen [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas]","volume":"46","author":"Golusi\u00f1ski","year":"1998","journal-title":"HNO"},{"key":"R15-7-20240907","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S0046-8177(99)90123-5","article-title":"Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: Close association with advanced disease stage and lymph node metastasis","volume":"30","author":"Zheng","year":"1999","journal-title":"Hum Pathol"},{"key":"R16-7-20240907","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.otohns.2005.08.026","article-title":"Decreased E-cadherin but not beta-catenin expression is associated with vascular invasion and decreased survival in head and neck squamous carcinomas","volume":"134","author":"Kurtz","year":"2006","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R17-7-20240907","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/his.12668","article-title":"The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma","volume":"67","author":"Cappellesso","year":"2015","journal-title":"Histopathology"},{"key":"R18-7-20240907","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s12253-014-9741-6","article-title":"Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma","volume":"20","author":"Ahmed","year":"2014","journal-title":"Pathol Oncol Res"},{"key":"R19-7-20240907","doi-asserted-by":"crossref","first-page":"E148","DOI":"10.1002\/lary.25736","article-title":"The prognostic role of E-cadherin and \u03b2-catenin overexpression in laryngeal squamous cell carcinoma","volume":"126","author":"Greco","year":"2016","journal-title":"Laryngoscope"},{"key":"R20-7-20240907","doi-asserted-by":"crossref","first-page":"30199","DOI":"10.18632\/oncotarget.25680","article-title":"The role of E-cadherin and \u03b2-catenin in laryngeal cancer","volume":"9","author":"Nardi","year":"2018","journal-title":"Oncotarget"}],"container-title":["Nigerian Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1693_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:15:02Z","timestamp":1787757302000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/njcp.njcp_1693_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/njcp.njcp_1693_21","relation":{},"ISSN":["1119-3077"],"issn-type":[{"value":"1119-3077","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}